---All---
  • ---All---
  • Accession
  • Catalog #

TRIM68 Antibody (C-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP17177b 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP17177b-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

TRIM68 Antibody (C-term) - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionQ6AZZ1
Other AccessionNP_060543.5
ReactivityHuman
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW56259 Da

TRIM68 Antibody (C-term) - Additional info

Gene ID 55128
Other Names
TRIM68; GC109; RNF137; SS56; E3 ubiquitin-protein ligase TRIM68; RING finger protein 137; SSA protein SS-56; Tripartite motif-containing protein 68
Target/Specificity
This TRIM68 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 381-411 amino acids from the C-terminal region of human TRIM68.
Dilution
WB~~1:100~500
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
TRIM68 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.

TRIM68 Antibody (C-term) - Protein Information

Name TRIM68
Synonyms GC109, RNF137, SS56
Function
Functions as an ubiquitin E3 ligase. Acts as a coactivator of androgen receptor (AR) depending on its ubiquitin ligase activity
Cellular Location
Cytoplasm, perinuclear region. Nucleus. Note=Colocalized with AR in nucleus
Tissue Location
Widely expressed. Expressed at high levels in prostate cancer cell lines. Up-regulation could be restricted to androgen-dependent cells

TRIM68 Antibody (C-term) - Related products

AP17177b: TRIM68 Antibody (C-term)

RI15469: TRIM68 predesign siRNA

AT4362a: TRIM68 Antibody (monoclonal) (M01)

TRIM68 Antibody (C-term) - Application data

  • TRIM68 Antibody (C-term) (Cat. #AP17177b) western blot analysis in NCI-H460 cell line lysates (35ug/lane).This demonstrates the TRIM68 antibody detected the TRIM68 protein (arrow).

TRIM68 Antibody (C-term) - Research Areas

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

The protein encoded by this gene contains a RING finger domain, a motif present in a variety of functionally distinct proteins and known to be involved in protein-protein and protein-DNA interactions. This gene is expressed in many cancer cell lines. Its expression in normal tissues, however, was found to be restricted to prostate. This gene was also found to be differentially expressed in androgen-dependent versus androgen-independent prostate cancer cells.

REFERENCES

Malhotra, A., et al. Diabetes Metab. Res. Rev. 25(8):740-747(2009) Miyajima, N., et al. Cancer Res. 68(9):3486-3494(2008) Chang, G.T., et al. Eur. J. Cancer 37(16):2129-2134(2001) Billaut-Mulot, O., et al. J. Clin. Invest. 108(6):861-869(2001) Simpson, J.C., et al. EMBO Rep. 1(3):287-292(2000)